Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02024087 |
| Title | Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Acceleron Pharma, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The University of Chicago Medical Center | Chicago | Illinois | United States | Details | ||
| University of Kansas Medical Center (KUMC) | Westwood | Kansas | United States | Details | ||
| Beth Israel Deaconess Medical Center (BIDMC) | Boston | Massachusetts | United States | Details | ||
| Hackensack University Medical Center | Hackensack | New Jersey | United States | Details | ||
| Memorial Sloan-Kettering Cancer Center | New York | New York | United States | Details | ||
| University of Rochester | Rochester | New York | United States | Details | ||
| University of Cincinnati Cancer Institute | Cincinnati | Ohio | United States | Details |